Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Biology of Reproduction|January 17, 2023
Sialyl Lewis X mediates interleukin-1 beta-induced trophoblast adhesion to endometrial cells during human embryo implantationZhi Ma, Mirjana Kessler, Anca Chelariu-Raicu, et al.
Biology of Reproduction|February 8, 2022
Prostaglandin E2 receptor 3 promotes M1 macrophages polarization in unexplained recurrent pregnancy lossYao Ye, Lin Peng, Anca Chelariu-Raicu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapyAnca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
Methods and Protocols|December 27, 2024
Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer OrganoidsSophia Hierlmayer, Liliia Hladchenko, Juliane Reichenbach, et al.
Fertility and Sterility|April 5, 2016
Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotypeAnca Chelariu-Raicu, Cornelia Wilke, Melanie Brand, et al.
International Journal of Molecular Sciences|May 28, 2022
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer PathogenesisLara Hillemeyer, Nancy Adriana Espinoza-Sanchez, Burkhard Greve, et al.
Frontiers in Immunology|June 17, 2021
Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained MiscarriagesZhi Ma, Huixia Yang, Lin Peng, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 6, 2020
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancerBrian M Slomovitz, Anca Chelariu-Raicu, Kathleen M Schmeler, et al.
Frontiers in Oncology|October 30, 2023
Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignanciesMarie Forster, Rachel Wuerstlein, Alexander Koenig, et al.
Molecular Cancer Therapeutics|September 18, 2020
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian CancerMark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu, et al.
Pageof 5